0001634389-17-000001.txt : 20170424 0001634389-17-000001.hdr.sgml : 20170424 20170424124743 ACCESSION NUMBER: 0001634389-17-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170424 DATE AS OF CHANGE: 20170424 EFFECTIVENESS DATE: 20170424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lyric Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001634389 IRS NUMBER: 464246084 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-234847 FILM NUMBER: 17777750 BUSINESS ADDRESS: STREET 1: 601 GATEWAY BLVD., SUITE 1020 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-277-5437 MAIL ADDRESS: STREET 1: 601 GATEWAY BLVD., SUITE 1020 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D/A 1 primary_doc.xml X0707 D/A LIVE 0001634389 Lyric Pharmaceuticals Inc. 601 GATEWAY BLVD., SUITE 1020 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 (650) 866-8070 DELAWARE None None Corporation true 2013 David Wurtman c/o Lyric Pharmaceuticals Inc. 601 Gateway Blvd., Suite 1020 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Casey Cunningham c/o Lyric Pharmaceuticals Inc. 601 Gateway Blvd, Suite 1020 South San Francisco CA CALIFORNIA 94080 Director Niall O'Donnell c/o Lyric Pharmaceuticals Inc. 601 Gateway Blvd, Suite 1020 San Francisco CA CALIFORNIA 94080 Director Jason Hong c/o Lyric Pharmaceuticals Inc. 601 Gateway Blvd., Suite 1020 South San Francisco CA CALIFORNIA 94080 Director Sanford Zweifach c/o Lyric Pharmaceuticals Inc. 601 Gateway Blvd., Suite 1020 South San Francisco CA CALIFORNIA 94080 Director M. Scott Harris c/o Lyric Pharmaceuticals Inc. 601 Gateway Blvd., Suite 1020 South San Francisco CA CALIFORNIA 94080 Executive Officer Pharmaceuticals Decline to Disclose 06b true 0001634389-15-000003 2015-02-11 false true false 0 33885598 26785593 7100005 $885,625.25 of the total amount sold is comprised of the conversion of principal and accrued interest in connection with outstanding convertible promissory notes. false 13 0 0 0 false Lyric Pharmaceuticals Inc. /s/ Glen Sato Glen Sato Secretary 2017-04-21